Patent details
EP3215122 Title: STABLE PROTEIN SOLUTION FORMULATION CONTAINING HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY
Basic Information
- Publication number:
- EP3215122
- PCT Application Number:
- US2015059571
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP157986092
- PCT Publication Number:
- WO2016073915
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- STABLE PROTEIN SOLUTION FORMULATION CONTAINING HIGH CONCENTRATION OF AN ANTI-VEGF ANTIBODY
- French Title of Invention:
- SOLUTION PROTEINIQUE STABLE CONTENANT UNE HAUTE CONCENTRATION DE ANTI-VEGF ANTICORPS
- German Title of Invention:
- STABILE PROTEINLÖSUNG ENTHALTEND EINE HOHEKONZENTRATION AN ANTI-VEGF-ANTIKÖRPER
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 12/09/2025
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 18/09/2025
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 13/08/2025
- Unitary Effect Registration Date:
- 18/09/2025
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 06/11/2015
- Grant date:
- 13/08/2025
- EP Publication Date:
- 13/09/2017
- PCT Publication Date:
- 12/05/2016
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 13/08/2025
- EP B1 Publication Date:
- 13/08/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 06/11/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 06/08/2025
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
Inventor
1
- Name:
- ALANI, Laman
- Address:
- United States (US)
2
- Name:
- ZHANG, Huixiang
- Address:
- United States (US)
3
- Name:
- ZENG, Yuhong
- Address:
- United States (US)
4
- Name:
- BORING, Charles
- Address:
- United States (US)
5
- Name:
- WAN, Li
- Address:
- United States (US)
6
- Name:
- KULSHRESHTHA, Alok
- Address:
- United States (US)
Priority
1
- Priority Number:
- 201462076770 P
- Priority Date:
- 07/11/2014
- Priority Country:
- United States (US)
2
- Priority Number:
- 201462088061 P
- Priority Date:
- 05/12/2014
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61P 43/00; C07K 16/22; A61P 27/02; A61K 9/00; A61K 39/395;
Publication
European Patent Bulletin
1
- Issue number:
- 202533
- Publication date:
- 13/08/2025
- Description:
- Grant (B1)
2
- Issue number:
- 202543
- Publication date:
- 22/10/2025
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202543
- Publication date:
- 22/10/2025
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|